Sentence examples for of trial discussions from inspiring English sources

This Article examines the theoretical, legal, and policy issues raised by this reform and presents the early results of a field experiment that tested the impact of trial discussions.

Noting how the content of trial discussions and researcher-defined quality of the consent were linked to parental ethnicity or clinician attitude towards parental ethnicity, Simon and Kodish [ 70] emphasise the danger of making assumptions based on ethnicity or socio-economic factors, which may contribute to the omission of important information for families.

Breast was chosen as the reference tumour group as these patients had the highest rate of trial discussion, and therefore the group against which we wished to contrast other tumour groups.

Research and specialist breast care nurses had a primary role in many of these trial discussions reflecting common practice in the United Kingdom.

Whilst oncology and neonatology tend to see good rates of trial participation, trial discussions in these settings often take place within hours or days of the family's first meeting with the clinical team suggesting that trust is not necessarily dependent on the longevity of a relationship.

Parents considering oncology and neonatal trials report particularly high levels of distress during trial discussions and a sense that this impairs their ability to ask questions or seek additional information [ 31] occasionally leading them to later doubt their decisions [ 32].

(Among the ideas that emerged: collating a directory of patients interested in participating in research and creating a "matchmaking" system with existing directories of clinical trials). Discussions continued on Friday morning at Johns Hopkins Sibley Innovation Hubb, where participants were able to follow-up and elaborate on ideas from the day before.

The items were developed based on a review of data from cinacalcet trials, discussions with clinical SHPT experts, a review of PRO measures that assess nausea/vomiting, and initial hypotheses regarding the endpoints that would be most appropriate for use in future efficacy trials of novel (i.e., non-cinacalcet) trials for SHPT.

In these drug approvals, we found drug approvals for diabetes are more likely than the other examined conditions to contain a discussion of trial evidence demonstrating that treatment effects on surrogate outcomes predict treatment effects on patient-centred outcomes.

Details of trial & some discussion of differences between French & American legal procedures.

Description of rationale and design of PROCON trial and discussion of its strengths and limitations.